Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

M. Cuffe, R. Califf, K. Adams, R. Benza, R. Bourge, W. Colucci, B. Massie, C. O'Connor, I. Pina, R. Quigg, M. Silver, Mihai Gheorghiade*, Marcus G. Hennersdorf

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)154-155
Number of pages2
JournalEvidence-based Cardiovascular Medicine
Issue number4
StatePublished - Jan 1 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this